Bristol-Myers Squibbb击败了Q3的收入,增加了投资,并宣布了0.60美元的红利。 Bristol-Myers Squibb beat Q3 earnings, saw increased investment, and declared a $0.60 dividend.

Bristol-Myers Squibb看到对Q3的机构投资增加,Kovitz投资集团和其他方面增加了他们的股权。 Bristol-Myers Squibb saw increased institutional investment in Q3, with Kovitz Investment Group and others boosting their stakes. 公司的收益超出预期,每股1.80美元,收入11.89亿美元. The company beat earnings expectations, reporting $1.80 per share and $11.89 billion in revenue. 布里斯托尔-迈尔斯宣布季度红利为0.60美元,收益4.04%。 Bristol-Myers declared a quarterly dividend of $0.60, yielding 4.04%. 分析员的评分好坏参半,协商一致的“坚持”和平均目标价格为54.07美元。 Analyst ratings are mixed, with a consensus "Hold" and average target price of $54.07.